Endobronchial carcinoid tumor is the most common malignant pulmonary tumor of the childhood tumors, accounting for 50 to 80% of childhood tumors. Endobronchial carcinoid tumor is generally accompanied by symptoms such as cough, hemoptysis, wheezing, weight loss, dyspnea, and chest pain, as well as by radiological symptoms including atelectasis, sclerosing lesion, infiltration, and lump patterns. This case report is about a patient whose asthma had been treated for several years but was not properly regulated, and who showed a unilateral overinflation in the chest x-ray that was diagnosed as an endobronchial carcinoid tumor after additional tests.
improvement of the symptoms through the treatment was slow, the peak expiratory flow rate (PEFR) was kept as low as 200 to 220 L/ml (normally higher than 325.6).
Allergy tests showed serum eosinophil count 190
/uL (reference value, 0 to 350 /uL), total IgE 75.57 U/ml (reference value, 0.5 to 393 U/ml), and eosinophil cationic protein (ECP) 9.82 /uL (reference value, 0 to 15/uL), all of which were in the normal ranges.
The ImmunoCAP lab tests showed a high European mite level of 16.5 kUA/L (reference value, 0 to 3.5) and a high American mite level of 29.5 kUA/L (reference value, 0 to 3.5).
In the tuberculosis tests, the result of the tuberculin test performed using purified protein derivatives (PPD) was less than 0.5 ㎜ (reference value, 1 cm or less). The sputum test result was negative.
There was neither weight loss nor contact with a tuberculosis patient, nor night sweats.
Before administration of a bronchodilator, the pulmonary function tests showed forced expiratory volume in 1second (FEV1) 52% (reference value, 80% or higher), forced vital capacity (FVC) 66% (reference value, 80% or higher), and FEV1/FVC 0.73 (reference value, 0.8 or higher) with respiratory obstruction.
After the administration of a bronchodilator, the test results were FEV1 59%, FVC 70%, and FEV1/FVC 77, and the increase of FEV1 by 13% (reference value, 12% or higher) indicated airway hyperreponsiveness (Fig. 1) .
The chest x-ray photography showed a pulmonary overinflation in both lungs, and the radiolucency of the left lung was significantly higher than that of the right lung (Fig. 2) . To verify the obstruction of the upper bronchus suspected by the unilateral increase of the radiolucency, chest high resolution computed tomography (HRCT) was performed. The HRCT showed a nodule of 1×1 ㎝ in size which blocked the left main bronchus in a check valve type (Fig. 3) . The bronchoscopy showed a round lump at the left main bronchus about 2 to 3 ㎝ from the tracheal bifurcation (Fig. 4) . The biopsy verified a typical carcinoid tumor. Thus, a thoracotomy was performed to solve the bronchial ob- The coughing and wheezing of the child patient were improved after the operation. The patient has been relatively healthy since his discharge, and has not undergone any treatment for asthma or pneumonia.
DISCUSSION
Primary pulmonary tumor is very rare in children.
Bronchial carcinoid tumor is the most common primary pulmonary tumor in children, accounting for 50 to 80% of pulmonary tumors in children or adolescents. 1 The ratio is about 1 to 2% in adults, but is particularly high among children during puberty. 2 The most common symptoms of bronchial carcinoid tumor are cough, hemoptysis, wheezing, weight loss, dyspnea, and chest pain. 3 Most of the tumors are found in the proximal part of the respiratory tract, where obstruction or hemorrhage is found as a symptom. Sometimes, cough, wheezing, hemoptysis, chest pain, or recurrent pneumonia may be repeatedly found in the same region. Chest CT, which is the most useful method of diagnosis, shows the range and location of the tumor as well as the relation with the mediastinum.
Bronchial carcinoid tumor of the typical type is accompanied by a mediastinal adenopathy in 5 to
20% of cases. 6 The case reported herein did not show a mediastinal adenopathy.
Bronchoscopy is implemented to confirm the diagnosis, and biopsy is possible in 3/4 of the patients.
Biopsy is allowed in most of the patients because of the low risk of severe hemorrhage. Differential diagnosis should be performed with diseases showing unilateral hyperlucent lung in chest x-ray radiography, most of which are found at the pulmonary parenchyma, respiratory tracts, pulmonary blood vessels, thorax, and mediastinum.
Representative diseases include Swayer-James or Macleod syndrome, congenital lobar emphysema, and pulmonary vascular abnormalities. Congenital cystic adenomatoid malformation, which is also a disease that should be differentiated, causes a harmartoma instead of normal pulmonary tissue. The disease may be diagnosed by prenatal ultrasonography, but if missed, hyperlucent lung is found by chest x-ray radiography or CT at the part where a pulmonary tissue has not been formed.
The disease may be accompanied by dyspnea, repeated pneumonia, or pneumothorax. 10 
